{
  "content": "Conclusion: Propranolol and pilsicainide appear to be cost-effective in patients with AF in Korea assuming that drug usage or compliance is the same. Key Words: ‌ \u0007 Atrial fibrillation, drugs, cost effectiveness, QALY Original Article pISSN: 0513-5796 · eISSN: 1976-2437 Received: July 12, 2019 Revised: October 13, 2019 Accepted: October 28, 2019 Co-corresponding authors: Changsoo Kim, MD, PhD, Department of Preventive Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.\nTel: 82-2-2228-1860, Fax: 82-2-392-8133, E-mail: preman@yuhs.ac and Boyoung Joung, MD, PhD, Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.",
  "source": "https://pdfs.semanticscholar.org/798d/e6aa4ebeb8836fdffb27a98ab4195330069c.pdf",
  "chunk_id": "f8bcddef-0f42-4955-830c-ecd8a15cd5b2",
  "similarity_score": 0.25871825218200684,
  "query": "cost effectiveness economic analysis amiodarone beta-blockers atrial fibrillation healthcare costs hospitalization reduction",
  "rank": 36,
  "title": "Cost-effectiveness of rate- and rhythm-control drugs for treating atrial fibrillation in Korea",
  "authors": "Min Kim, Woojin Kim, Changsoo Kim, Boyoung Joung",
  "year": "2019",
  "journal": "Yonsei Medical Journal",
  "reference": "Kim, M., Kim, W., Kim, C., & Joung, B. (2019). Cost-effectiveness of rate- and rhythm-control drugs for treating atrial fibrillation in Korea. Yonsei Medical Journal, 60(12), 1157-1163. https://doi.org/10.3349/ymj.2019.60.12.1157",
  "doi": "10.3349/ymj.2019.60.12.1157",
  "chunk_index": 6,
  "total_chunks": 62,
  "retrieved_at": "2025-07-24T21:58:16.915877"
}